Trial record 19 of 218 for:    Open Studies | "Cystic Fibrosis"

Transfer Impedance in Cystic Fibrosis (Ztr)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Children's Hospital Boston.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00743158
First received: August 27, 2008
Last updated: August 19, 2009
Last verified: August 2009
  Purpose

This study aims to determine whether respiratory system transfer impedance (Ztr) may fill an important clinical function by providing a reproducible, valid, and sensitive measure of airway obstruction in people with CF.


Condition
Cystic Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Transfer Impedance in Cystic Fibrosis (Ztr)

Resource links provided by NLM:


Further study details as provided by Children's Hospital Boston:

Estimated Enrollment: 40
Study Start Date: August 2008
  Eligibility

Ages Eligible for Study:   2 Years to 25 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Cystic Fibrosis Patients

Criteria

Inclusion Criteria:

  • Between the ages of 2 to 25 Confirmed diagnosis of Cystic Fibrosis

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00743158

Locations
United States, Massachusetts
Childrens Hospital, Boston Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lamia Momen, BA    617-355-6665    lamia.momen@childrens.harvard.edu   
Principal Investigator: Thomas R Martin, MD         
Sponsors and Collaborators
Children's Hospital Boston
  More Information

No publications provided

Responsible Party: Thomas Martin, MD, Childrens Hospital, Boston
ClinicalTrials.gov Identifier: NCT00743158     History of Changes
Other Study ID Numbers: X08-01-0060
Study First Received: August 27, 2008
Last Updated: August 19, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
ztr
transfer impedance
cystic fibrosis
pulmonary function test
pft

Additional relevant MeSH terms:
Cystic Fibrosis
Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on July 24, 2014